Absence of minimal residual disease (MRD) by reverse transcription polymerase chain reaction (RT-PCR) in CBF beta/MYH11-associated acute myeloid leukemia.

被引：0
|
作者：
Marcucci, G
Caligiuri, MA
Oberkircher, AR
Bloomfield, CD
机构：
[1] OHIO STATE UNIV,DIV HEMATOL ONCOL,COLUMBUS,OH 43210
[2] OHIO STATE UNIV,ARTHUR G JAMES CANC HOSP,DIV HUMAN CANC GENET,COLUMBUS,OH 43210
[3] OHIO STATE UNIV,RES INST,COLUMBUS,OH 43210
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：270 / 270
页数：1
相关论文
共 50 条
  • [41] Characteristics of Ebola Virus Disease Survivor Blood and Semen in Liberia: Serology and Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    Kofman, Aaron
    Linderman, Susanne
    Su, Kaihong
    Purpura, Lawrence J.
    Ervin, Elizabeth
    Brown, Shelley
    Morales-Betoulle, Maria
    Graziano, James
    Cannon, Deborah L.
    Klena, John D.
    Desamu-Thorpe, Rodel
    Fankhauser, John
    Orone, Romeo
    Moses, Soka
    Glaybo, Uriah
    Massaquoi, Moses
    Nyenswah, Tolbert
    Nichol, Stuart T.
    Kollie, Jomah
    Kiawu, Armah
    Freeman, Edna
    Giah, Giovanni
    Tony, Henry
    Faikai, Mylene
    Jawara, Mary
    Kamara, Kuku
    Kamara, Samuel
    Flowers, Benjamin
    Mohammed, Kromah
    Chiriboga, David
    Williams, Desmond E.
    Hinrichs, Steven H.
    Ahmed, Rafi
    Vonhm, Benjamin
    Rollin, Pierre E.
    Choi, Mary J.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E3641 - E3646
  • [42] Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR)
    Weber, Axel
    Taube, Sylvia
    Stadt, Udo Zur
    Horstmann, Martin
    Krohn, Knut
    Bradtke, Jutta
    Teigler-Schlegel, Andrea
    Leiblein, Sabine
    Christiansen, Holger
    EXPERIMENTAL HEMATOLGY & ONCOLOGY, 2012, 1
  • [43] Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR)
    Axel Weber
    Sylvia Taube
    Udo zur Stadt
    Martin Horstmann
    Knut Krohn
    Jutta Bradtke
    Andrea Teigler-Schlegel
    Sabine Leiblein
    Holger Christiansen
    Experimental Hematology & Oncology, 1 (1)
  • [44] Evaluation of minimal residual disease (MRD) in inv(16) positive AMLS by qualitative and quantitative RT-PCR assays of CBFb/MYH11 fusion transcripts.
    Guerrasio, A
    De Micheli, D
    Pilatrino, C
    Gottardi, E
    Serra, A
    Tessore, N
    Volpe, G
    Marmont, F
    Melillo, L
    Diverio, D
    Lo Coco, F
    Saglio, G
    BLOOD, 2000, 96 (11) : 312A - 312A
  • [45] Minimal residual disease (MRD) analysis in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)] by real time PCR (RT-PCR) and flow cytometry (FC).
    Perea, G
    Lasa, A
    Aventin, A
    Domingo, A
    Villamor, N
    de Llano, MPQ
    Llorente, A
    Junca, J
    Palacios, C
    Fernandez, C
    Gilallart, M
    Font, L
    Tormo, M
    Florensa, L
    Bargay, J
    Marti, JM
    Vivancos, P
    Torres, P
    Berlanga, J
    Brunet, S
    Sierra, J
    Nomdedeu, JF
    BLOOD, 2004, 104 (11) : 817A - 817A
  • [46] ABSENCE OF REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION DETECTABLE RESIDUAL DISEASE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA IN LONG-TERM REMISSION
    DIVERIO, D
    PANDOLFI, PP
    BIONDI, A
    AVVISATI, G
    PETTI, MC
    MANDELLI, F
    PELICCI, PG
    LOCOCO, F
    BLOOD, 1993, 82 (12) : 3556 - 3559
  • [47] Fluorescence in situ hybridisation (FISH) compared with reverse transcription polymerase chain reaction (RT-PCR) for analysing individual hematopoietic colonies derived from chronic myeloid leukemia samples
    Thijsen, SFT
    Schuurhuis, GJ
    vanOostveen, JW
    Theijsmeijer, AP
    Langenhuijsen, MMAC
    Ossenkoppele, GJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 768 - 768
  • [48] Detection of histo-blood group ABO mRNA in human chronic myeloid leukemia cell lines using reverse transcription-polymerase chain reaction (RT-PCR)
    Hosoi, E
    Hirose, M
    Hamano, S
    Kuroda, Y
    CANCER LETTERS, 1998, 133 (02) : 191 - 196
  • [49] Assessment of minimal residual disease (MRD) by qualitative RT-PCR (Q-PCR) vs real-time quantitative RT-PCR (RQ-PCR) in a phase II study of acute promyelocytic leukemia (APL)
    Gallagher, RE
    Schachter-Tokarz, EL
    Jones, DA
    Estey, EH
    BLOOD, 2005, 106 (11) : 912A - 912A
  • [50] Tandem application of flow Cytometry and polymerase chain reaction for choice targets of minimal residual disease in childhood acute lymphoblastic leukemia.
    Tie, LJ
    Gu, LJ
    Jiang, LM
    BLOOD, 2005, 106 (11) : 201B - 201B
12345